The impact of asthma and/or COPD on work absence

B. Dierick (Groningen, Netherlands), B. Flokstra-De Blok (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), N. Toledo-Pons (Palma de Mallorca, Spain), M. Roman-Rodriguez (Palma de Mallorca, Spain), B. Cosio (Palma de Mallorca, Spain), J. Soriano (Madrid, Spain), J. Kocks (Groningen, Netherlands), J. van Boven (Groningen, Netherlands)

Source: International Congress 2018 – Primary care management of asthma
Session: Primary care management of asthma
Session type: Thematic Poster
Number: 4216
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Dierick (Groningen, Netherlands), B. Flokstra-De Blok (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), N. Toledo-Pons (Palma de Mallorca, Spain), M. Roman-Rodriguez (Palma de Mallorca, Spain), B. Cosio (Palma de Mallorca, Spain), J. Soriano (Madrid, Spain), J. Kocks (Groningen, Netherlands), J. van Boven (Groningen, Netherlands). The impact of asthma and/or COPD on work absence. 4216

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of COVID-19 on patients with asthma
Source: Eur Respir J, 57 (3) 2003142; 10.1183/13993003.03142-2020
Year: 2021



The occupational contribution to severe exacerbation of current asthma
Source: Annual Congress 2009 - Environmental factors, susceptibility, asthma and COPD
Year: 2009


The clinical importance of small airway involvement in patients with asthma and COPD
Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD
Year: 2019


COPD and its impact on ability to continue to work
Source: Annual Congress 2011 - The work environment in the clinic
Year: 2011


A quantitative European study to investigate the impact of asthma triggers on the lives of asthma patients
Source: Annual Congress 2011 - The work environment in the clinic
Year: 2011

Comparative study about the permanent work capacity impairment in COPD and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 453s
Year: 2006

Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015

Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


The impact of spirometery on family physician‘s care of asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 670s
Year: 2005

Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007



Reduction of work exposure is not associated with improvement in functional and biological findings in occupational asthma
Source: Annual Congress 2006 - Asthma at the workplace – the prognosis and the costs
Year: 2006


LATE-BREAKING ABSTRACT: The prevalence of night and morning symptoms in primary care COPD patients: How do they relate to COPD health status and disease severity? An UNLOCK study
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Why is it important to consider (sub)phenotypes of asthma and COPD?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005

COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Impact of stable state symptoms on the future burden of COPD exacerbations
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




COPD exacerbations: impact and prevention
Source: Breathe 2013; 9: 434-440
Year: 2013

The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013

A global survey conducted to determine frequency of exacerbations in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013